Viewing StudyNCT05128734



Ignite Creation Date: 2024-05-06 @ 4:54 PM
Last Modification Date: 2024-10-26 @ 2:18 PM
Study NCT ID: NCT05128734
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-01-31
First Post: 2021-10-27

Brief Title: Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer TNBC
Sponsor: AHS Cancer Control Alberta
Organization: AHS Cancer Control Alberta

Conditions & Keywords Data

Conditions:
Name
Breast Cancer Triple Negative
Keywords:
Name View
Olaparib View
METHYLATED 06-methylguanine-DNA methyltransferase MGMT View
Triple-Negative Breast Cancer View
TNBC View
Temozolomide View